BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15047755)

  • 1. CD20 positive T cell lymphoma: is it a real entity?
    Sun T; Akalin A; Rodacker M; Braun T
    J Clin Pathol; 2004 Apr; 57(4):442-4. PubMed ID: 15047755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
    Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
    Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD20-positive T cell leukemia/lymphoma: case report and review of the literature.
    Yokose N; Ogata K; Sugisaki Y; Mori S; Yamada T; An E; Dan K
    Ann Hematol; 2001 Jun; 80(6):372-5. PubMed ID: 11475154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
    Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
    Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.
    Kakinoki Y; Hashiguchi J; Ishio T; Chiba K; Niino D; Ohshima K
    Int J Hematol; 2015 Dec; 102(6):702-8. PubMed ID: 26251099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nijmegen breakage syndrome-associated T-cell-rich B-cell lymphoma: case report.
    Paulli M; Viglio A; Boveri E; Pitino A; Lucioni M; Franco C; Riboni R; Rosso R; Magrini U; Marseglia GL; Marchi A
    Pediatr Dev Pathol; 2000; 3(3):264-70. PubMed ID: 10742414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
    Wang X; Ng CS; Chen C; Yu G; Yin W
    Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
    Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
    Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD20-Positive nodal natural killer/T-cell lymphoma with cutaneous involvement.
    Tsai YC; Chen CK; Wu YH
    J Cutan Pathol; 2015 Sep; 42(9):639-44. PubMed ID: 25924981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD20 positive mycosis fungoides: a case report.
    Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
    J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy.
    Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Cancer Sci; 2009 Jan; 100(1):54-61. PubMed ID: 19038008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20 positive T-cell lymphoma/leukemia: a rare entity with potential diagnostic pitfalls.
    Buckner CL; Christiansen LR; Bourgeois D; Lazarchick JJ; Lazarchick J
    Ann Clin Lab Sci; 2007; 37(3):263-7. PubMed ID: 17709692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20-positive T-cell lymphoma with indolent clinical behaviour.
    Xiao WB; Wang ZM; Wang LJ
    J Int Med Res; 2010; 38(3):1170-4. PubMed ID: 20819457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
    Chu PG; Loera S; Huang Q; Weiss LM
    Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal CD20-positive peripheral T-cell lymphoma presenting with adrenal and testicular masses.
    Makita M; Murakami I; Yoshioka T; Tanaka H; Yamamoto K; Imajo K; Takata K; Yoshino T
    Rinsho Ketsueki; 2009 May; 50(5):413-8. PubMed ID: 19483402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival T-cell lymphoma: a clinicopathologic case report.
    Al-Muammar A; Hodge WG; Farmer J
    Ophthalmology; 2006 Mar; 113(3):459-61. PubMed ID: 16427701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD20-positive primary nasal peripheral T-cell lymphoma: An analysis of one case and review of the literature.
    Li YL; Wang HP; Zhang C; Zhai ZM
    Cytometry B Clin Cytom; 2020 Jul; 98(4):348-354. PubMed ID: 31682318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
    Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
    Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.